pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

7,970 catalysts · 5,347 phase readout · 2,277 8k filing · 343 pdufa · 254 earnings · 2 approval · 1 adcom

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-08-03: 4 catalysts2026-08-04: 13 catalysts2026-08-05: 17 catalysts2026-08-06: 11 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 2 catalysts2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 1 catalyst2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 1 catalyst2026-10-22: 2 catalysts2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts2026-10-26: 0 catalysts2026-10-27: 2 catalysts2026-10-28: 1 catalyst2026-10-29: 3 catalysts2026-10-30: 0 catalysts2026-10-31: 0 catalysts2026-11-01: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type
  • phase readout5,347
  • 8k filing2,277
  • pdufa343
  • earnings254
  • approval2
  • adcom1
therapy area

no tagged catalysts yet

Date TBD

50
›COMPLETEDphase readoutNCT07521306: Biomarkers for Predicting Mortality in Patients With Suspected Sepsis

Sponsor: Antalya Training and Research Hospital. Phase: . Conditions: Sepsis, Mortality, Biomarkers

full page →ctgov ↗
›RECRUITINGphase readoutNCT07190404: Multicontext Approach for Cognitive Function in Parkinson Disease

Sponsor: Washington University School of Medicine. Phase: NA. Conditions: PARKINSON DISEASE (Disorder)

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07542704: A Study to Investigate the Safety and Efficacy of KQB368 as Monotherapy in Participants With Advanced Solid Malignancies

Sponsor: Kumquat Biosciences Inc.. Phase: PHASE1. Conditions: Advanced Solid Tumors, Colorectal Cancer (CRC), Non-Small Cell Lung Cancer, Uterine Cancer, KRAS G12C Mutations, KRAS G12S Mutations

full page →ctgov ↗
›RECRUITINGphase readoutNCT05484804: Accountability for Care Through Undoing Racism & Equity for Moms

Sponsor: University of North Carolina, Chapel Hill. Phase: NA. Conditions: Pregnancy Related, Maternal Health, Maternal Mortality, Low Birthweight, Racism, Implicit Bias

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT03970304: CVD 37000: Immunity and Microbiome Studies at Intestinal and Systemic Sites in Ty21a Vaccinated Adults

Sponsor: University of Maryland, Baltimore. Phase: PHASE4. Conditions: Typhoid Vaccination

full page →ctgov ↗
›COMPLETEDphase readoutNCT03867084: Safety and Efficacy of Pembrolizumab (MK-3475) Versus Placebo as Adjuvant Therapy in Participants With Hepatocellular Carcinoma (HCC) and Complete Radiological Response After Surgical Resection or Local Ablation (MK-3475-937 / KEYNOTE-937)

Sponsor: Merck Sharp & Dohme LLC. Phase: PHASE3. Conditions: Hepatocellular Carcinoma

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT04432584: A Study Evaluating the Safety, Pharmacokinetics, and Efficacy of Crovalimab Versus Eculizumab in Participants With Paroxysmal Nocturnal Hemoglobinuria (PNH) Currently Treated With Complement Inhibitors

Sponsor: Hoffmann-La Roche. Phase: PHASE3. Conditions: Paroxysmal Nocturnal Hemoglobinuria

full page →ctgov ↗
›COMPLETEDphase readoutNCT04512547: Oxidative Stress in Asthma

Sponsor: Bastiaan Driehuys. Phase: PHASE2. Conditions: Asthma, Obesity

full page →ctgov ↗
›COMPLETEDphase readoutNCT07384247: Trigger Point Dry Needling With and Without Electrical Stimulation in Healthy Subjects

Sponsor: University of Rhode Island. Phase: NA. Conditions: People With Identified Painful Trigger Points (Tp) Within the Soleus and Gastrocnemius Muscles Complex, Healthy Subjects or Volunteers

full page →ctgov ↗
›WITHDRAWNphase readoutNCT03740347: Chronic Non-inflammatory Pains in Rheumatopediatrics

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: . Conditions: Juvenile Idiopathic Arthritis

full page →ctgov ↗
›TERMINATEDphase readoutNCT03498638: Feasibility Study of Couple Therapy Treatment for Situational Couple Violence

Sponsor: University Hospitals Cleveland Medical Center. Phase: NA. Conditions: Violence, Domestic

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07524049: Giving Children a Voice in Paediatric Anaesthesia

Sponsor: Insel Gruppe AG, University Hospital Bern. Phase: . Conditions: Perioperative Care, Pediatric Anesthesia, Pain Management, Anxiety, Research Agenda, Research Subjects

full page →ctgov ↗
›TERMINATEDphase readoutNCT03348748: Stereotactic Body Radiation Therapy Followed by Surgery in Treating Patients With Stage I-IIIA Non-small Cell Lung Cancer

Sponsor: Roswell Park Cancer Institute. Phase: EARLY_PHASE1. Conditions: Stage I Non-Small Cell Lung Cancer AJCC v7, Stage IA Non-Small Cell Lung Carcinoma AJCC v7, Stage IB Non-Small Cell Lung Carcinoma AJCC v7, Stage II Non-Small Cell Lung Cancer AJCC v7, Stage IIA Non-Small Cell Lung Carcinoma AJCC v7, Stage IIB Non-Small Cell Lung Carcinoma AJCC v7, Stage IIIA Non-Small Cell Lung Cancer AJCC v7

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07380555: The Effectiveness and Safety of Artificial Intelligence(AI)-Assisted Medical Treatment Decision Support System Compared to Conventional Care in HFrEF Patients

Sponsor: Shanghai Zhongshan Hospital. Phase: NA. Conditions: Heart Failure With Reduced Ejection Fraction (HF-rEF)

full page →ctgov ↗
›RECRUITINGphase readoutNCT05367635: A Study of SKB315 in Patients With Advanced Solid Tumors

Sponsor: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Phase: PHASE1. Conditions: Advanced Solid Tumors

full page →ctgov ↗
›RECRUITINGphase readoutNCT02639325: Tumor Related Epilepsy

Sponsor: National Institute of Neurological Disorders and Stroke (NINDS). Phase: . Conditions: Epilepsy, Cancer, Brain Neoplasm

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05778825: A Study of Oral Minoxidil to Treat Hair Loss in Children, Teens, and Young Adults Who Are Cancer Survivors

Sponsor: Memorial Sloan Kettering Cancer Center. Phase: PHASE2. Conditions: Survivors of Childhood Cancer, Alopecia

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT06007976: LLLT to Reduce Low Back Pain

Sponsor: Mayo Clinic. Phase: NA. Conditions: Low Back Pain

full page →ctgov ↗
›RECRUITINGphase readoutNCT06445140: Dynamics of Motivational Factors for Physical Activity and Nutrition in Oncogeriatrics

Sponsor: Institut du Cancer de Montpellier - Val d'Aurelle. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›COMPLETEDphase readoutNCT02761889: Hypofractionated Image-Guided Radiotherapy (IGRT) With Organ Motion Mitigation and Urethral Sparing for Prostate Cancer

Sponsor: Fundacao Champalimaud. Phase: NA. Conditions: Adenocarcinoma of the Prostate

full page →ctgov ↗
›RECRUITINGphase readoutNCT07500090: A Phase 3 Efficacy and Safety Study of HBS-301 in Participants With Idiopathic Hypersomnia (IH)

Sponsor: Harmony Biosciences Management, Inc.. Phase: PHASE3. Conditions: Idiopathic Hypersomnia

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07084090: Using IF-THEN Plans to Support Patients in Raising Safety Concerns About Their Care

Sponsor: University of Manchester. Phase: NA. Conditions: Patient Safety Concerns

full page →ctgov ↗
›RECRUITINGphase readoutNCT06118697: Feasibility of Aerodigestive Stimulation Therapy Trial

Sponsor: Sudarshan Jadcherla. Phase: NA. Conditions: Feeding Disorder Neonatal

full page →ctgov ↗
›RECRUITINGphase readoutNCT05780710: OBPM_Meds2023: Multicentric Prospective Clinical Study to Evaluate the Aktiia Optical Blood Pressure Monitoring (OBPM) Device Compared to Standard Home Blood Pressure Monitoring (HBPM) in Hypertensive Patients When Blood Pressure Lowering Medications Intake

Sponsor: Aktiia SA. Phase: NA. Conditions: Hypertension

full page →ctgov ↗
›RECRUITINGphase readoutNCT07412613: Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

Sponsor: Akeso. Phase: PHASE3. Conditions: Resectable Colon Cancer, MSI-H/dMMR Colorectal Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT05937620: Sentinel Node Detection With Technetium-99m Albumin Nanocolloid and ICG in Patients With Epithelial Ovarian Cancer

Sponsor: Fundacion Clinic per a la Recerca Biomédica. Phase: NA. Conditions: Ovarian Epithelial Cancer

full page →ctgov ↗
›TERMINATEDphase readoutNCT04717024: The Nanowear Wearable Covid-19 Observational and Analysis Trend

Sponsor: Nanowear Inc.. Phase: . Conditions: Covid19

full page →ctgov ↗
›COMPLETEDphase readoutNCT06381024: A Study of Telemonitoring in Cancer Patients

Sponsor: Centre Hospitalier de Bligny. Phase: NA. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT06469970: Evolution of the Initial Distribution Volume of Glucose in the Severe Burned Adults

Sponsor: Centre Hospitalier Régional Metz-Thionville. Phase: PHASE2. Conditions: Burns, Intensive Care, Emergencies

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT06963970: Using Community Health Workers to Support Rural Care Partners of Seriously Ill Older Veterans

Sponsor: VA Office of Research and Development. Phase: NA. Conditions: Dementia, Cancer, Renal Disease, Obstructive Pulmonary Disease

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07432373: Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection

Sponsor: National University of Malaysia. Phase: . Conditions: Pleural Infection

full page →ctgov ↗
›COMPLETEDphase readoutNCT07612969: Comparing The Effect of Proprioceptive Neuromuscular Facilitation (PNF) When Coupled With Dry Needling (DN), Acupuncture (AN) or Sham Needling (SN) on Knee Range of Motion (ROM), Jump Height and Unipedal Balance

Sponsor: Mohamad Karam. Phase: NA. Conditions: Healthy Adult Males, Healthy Subjects

full page →ctgov ↗
›RECRUITINGphase readoutNCT07572669: Moxibustion for Steroid-Refractory Acute Graft-Versus-Host Disease After Allogeneic Hematopoietic Stem Cell Transplantation

Sponsor: Union Hospital, Tongji Medical College, Huazhong University of Science and Technology. Phase: PHASE2. Conditions: Steroid-Refractory Acute Graft-Versus-Host Disease, Acute Graft-Versus-Host Disease, Graft-Versus-Host Disease, Allogeneic Hematopoietic Stem Cell Transplantation

full page →ctgov ↗
›RECRUITINGphase readoutNCT07593183: Comparing the Effects of Lumbar Stability Exercises and Telerehabilitation on Reducing Lumbar Lordotic Angle, Pain, and Disability in Postpartum Women

Sponsor: Foundation University Islamabad. Phase: NA. Conditions: Lumbar Lordotic Angle, Lumbar Pain, Disability

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07406841: Spinal Versus General Anesthesia in Pregnancies With Placenta Accreta Spectrum: A Retrospective Comparative Study

Sponsor: Gaziantep City Hospital. Phase: . Conditions: Placenta Accreta Spectrum

full page →ctgov ↗
›RECRUITINGphase readoutNCT07504341: Physiological Finding in Management of COVID 19 Patients

Sponsor: St. Martin De Porress Hospital. Phase: . Conditions: COVID-19 (Coronavirus Disease 2019)

full page →ctgov ↗
›RECRUITINGphase readoutNCT07306754: A Phase 1 Study to Evaluate the Safety and Pharmacokinetics of ABBV-243 in Healthy Adults.

Sponsor: AbbVie. Phase: PHASE1. Conditions: Healthy Volunteers

full page →ctgov ↗
›ENROLLING_BY_INVITATIONphase readoutNCT05396105: Extension Study of Oral PHA-022121 for Acute Treatment of Angioedema Attacks in Patients With Hereditary Angioedema

Sponsor: Pharvaris Netherlands B.V.. Phase: PHASE2. Conditions: Hereditary Angioedema, Hereditary Angioedema Type I, Hereditary Angioedema Type II, Hereditary Angioedema Types I and II, Hereditary Angioedema Attack, Hereditary Angioedema With C1 Esterase Inhibitor Deficiency, Hereditary Angioedema - Type 1, Hereditary Angioedema - Type 2, Hereditary Angioedema - Type 3, C1 Esterase Inhibitor [C1-INH] Deficiency, C1 Esterase Inhibitor Deficiency, C1 Esterase Inhibitor, Deficiency of, C1 Inhibitor Deficiency, Hereditary Angioedema Type III, Hereditary Angioedema (HAE), Hereditary Angioedema Type I and II

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07541105: Cancer Awareness Among Syrian Migrants

Sponsor: Toros University. Phase: NA. Conditions: Breast Cancer Screening, Cervical Cancer Screening, Colorectal Cancer Screening, Cancer Prevention Behavior

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07531394: Safety and Efficacy of Remote Ischemic Conditioning in Patients With Acute Myocardial Injury Following Acute Ischemic Stroke

Sponsor: Capital Medical University. Phase: PHASE3. Conditions: Ischemic Stroke, Acute, Myocardial Injury

full page →ctgov ↗
›RECRUITINGphase readoutNCT05535166: Molecular and Clinical Risk-Directed Therapy for Infants and Young Children With Newly Diagnosed Medulloblastoma

Sponsor: St. Jude Children's Research Hospital. Phase: PHASE2. Conditions: Medulloblastoma

full page →ctgov ↗
›COMPLETEDphase readoutNCT07461766: Food and Nutrition Education for Adolescent Soccer Players

Sponsor: Federal University of São Paulo. Phase: NA. Conditions: Nutritional Assessments, Adolescent Athletic Performance, Premenstrual Syndrome

full page →ctgov ↗
›RECRUITINGphase readoutNCT03524222: Home Hospital for Suddenly Ill Adults

Sponsor: Brigham and Women's Hospital. Phase: NA. Conditions: Infection, Heart Failure, COPD, Asthma, Gout Flare, Chronic Kidney Diseases, Hypertensive Urgency, Atrial Fibrillation Rapid, Anticoagulants; Increased

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT05656651: Acute Immunological Effects of Exercise in Cancer Patients

Sponsor: Universität Duisburg-Essen. Phase: PHASE2. Conditions: Cancer

full page →ctgov ↗
›RECRUITINGphase readoutNCT07473531: Chatbot to Support Healthcare Professionals Experiencing Workplace Aggression

Sponsor: Distrito Sanitario Almeria. Phase: . Conditions: Workplace Violence, Health Professionals, Chatbot, Digital Health

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07427472: "Detection and Follow-up of Coronary Lesions in HeFH (DESTINY-FH Study)"

Sponsor: Assistance Publique - Hôpitaux de Paris. Phase: NA. Conditions: Heterozygous Familial Hypercholesterolemia (HeFH)

full page →ctgov ↗
›ACTIVE_NOT_RECRUITINGphase readoutNCT07465939: Dento-skeletal Effects of Quadhelix Versus Mini-hyrax Expanders in Patients With Cleft Lip and Palate at the Mixed Dentition Stage: A Randomized Clinical Trial

Sponsor: Cairo University. Phase: NA. Conditions: Maxillary Expansion in Cleft Lip and Palate Patients, Dentoskeletal Effects After Expansion Using Two Different Expanders

full page →ctgov ↗
›NOT_YET_RECRUITINGphase readoutNCT07569575: Magnesium-Titanium Hybrid Intramedullary Nail System For Long Bone Fractures

Sponsor: HuaMg Perfection Med Tech (Suzhou) Co., Ltd.. Phase: NA. Conditions: Tibial Fracture, Femoral Fracture, Humeral Fracture

full page →ctgov ↗
›RECRUITINGphase readoutNCT07422675: SAD Study in Patients With Parkinson's Disease and Motor Fluctuations

Sponsor: Serina Therapeutics. Phase: PHASE1. Conditions: PARKINSON DISEASE (Disorder), Advanced Parkinson's Disease

full page →ctgov ↗
›RECRUITINGphase readoutNCT07439575: Wound Closure Materials and Techniques in Hip and Knee Arthroplasty

Sponsor: Bahattin Kemah. Phase: NA. Conditions: Osteoarthritis, Knee, Osteoarthritis, Hip

full page →ctgov ↗
← prev
page 90 of 160
next →